Literature DB >> 20065912

Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.

Josef Finsterer, Marlies Frank, Elisabeth Krexner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065912     DOI: 10.1097/SMJ.0b013e3181c81b93

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  1 in total

1.  Treatment of ocular myasthenia gravis.

Authors:  Scott R Haines; Matthew J Thurtell
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.